February 3, 2024

Helicobacter pylori, a Gram-negative bacterium with significant implications for public health, is the culprit behind gastritis, peptic ulcers, and, alarmingly, has been classified as a Class 1 carcinogen due to its link to cancer. Novala Biotech, committed to advancing diagnostics, has introduced H Pylori antigen test kits, boasting unparalleled sensitivity, specificity, and affordability compared to existing methods, making them a game-changer in the landscape of STI diagnostics.

Unmasking the Prevalence of H. pylori Infections

A comprehensive hospital-based study at Chitwan Medical College Teaching Hospital underscored the pervasive nature of H. pylori infections, with 16% of suspected patients testing positive for H. pylori stool antigen (HpSAg). Notably, children under the age of 10 exhibited an alarming 36% infection rate, emphasizing the urgency of precise diagnostic tools. Novala Biotech’s dedication to combating this silent threat is manifested in their advanced antigen test kits.

Clinical Presentation and Consequences of H. pylori Infection

Despite often being asymptomatic, H. pylori infections can lead to severe consequences, including peptic ulcer disease and gastric adenocarcinoma. Recognizing the significance of early detection, Novala Biotech’s H Pylori antigen test kits empower individuals to take control of their health, offering a window into the silent progression of this bacterium.

The Diagnostic Dilemmas of H. pylori

Existing diagnostic methods, including serology, urea breath tests, and histology, PCR to sensitivity, specificity, and reliability. The absence of a definitive “gold standard” further complicates accurate diagnosis. Novala Biotech addresses these challenges head-on with H Pylori antigen test kits, providing a reliable alternative with heightened sensitivity and specificity. Thoughthe PCR based test are more reliable , but in a country like Nepal, with low resource settings especially in sub urban areas and poor economic condition, H pylori Antigen based kits are more appropriate and easy to use by lab technicians.

Novala Biotech’s H Pylori Antigen Test Kits with precision on results

Compared to established methods like PCR and culture, Novala Biotech’s H Pylori antigen test kits emerge as a beacon on diagnosis. Boasting superior sensitivity and specificity, these kits provide accurate results without the risk of contamination. The affordability and ease of use make them particularly advantageous, especially in low-resource settings, marking a paradigm shift in the landscape of H pylori diagnostics.

A Closer Look at Sensitivity and Specificity

In-depth comparisons reveal that Novala Biotech’s H Pylori antigen test kits outshine other methods. While the sensitivity and specificity of established methods range from 55% to 100%, Novala Biotech’s kits consistently deliver higher accuracy with sensitivity and specificity up to 100% as per the clinical validation performed in Nepal. Hence, bridging the diagnostic gap with reliability that is crucial for patient care.


 In the ever-evolving field of H. pylori diagnostics, Novala Biotech’s H Pylori antigen test kits emerge as a revolutionary force. With heightened sensitivity, specificity, affordability, and ease of use, these kits redefine the standards for accurate and accessible H pylori testing. Opting for Novala Biotech means choosing a reliable partner in safeguarding your customers health, with solutions tailored for both developed and developing regions. Don’t compromise on accuracy – choose Novala Biotech’s H Pylori antigen test kits for a brighter and healthier future.


  1. Ansari, S., Gautam, R., Nepal, H.P. et al. Helicobacter pylori colonization in Nepal; assessment of prevalence and potential risk factors in a hospital-based patient cohort. BMC Res Notes 9, 59 (2016).

  2. Patel SK, Pratap CB, Jain AK, Gulati AK, Nath G. Diagnosis of Helicobacter pylori: what should be the gold standard? World J Gastroenterol. 2014 Sep 28;20(36):12847-59. doi: 10.3748/wjg.v20.i36.12847. PMID: 25278682; PMCID: PMC4177467.

  3. Mayo Clinic. (n.d.). Helicobacter pylori infection: Diagnosis & treatment.

  4. Center for Disease Control and Prevention (CDC). (2024). Helicobacter pylori.